BackMannkind Overview
Mannkind Corp

Mannkind Target Price

Where could MNKD trade next? Consensus target price: $10.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.85

Average Target Price

$10.43170.9% upside

7 analysts in the last 4 months

High: $14 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-06Wells Fargo$13237.7% upsideOpen
2026-07-30Wells Fargo$14263.6% upsideOpen
2026-06-01Wells Fargo$11185.7% upsideOpen
2026-05-07Mizuho SecuritiesAnthony Petrone$781.8% upsideOpen
2026-05-07Wells Fargo$10159.7% upsideOpen
2026-05-07H.C. Wainwright$10159.7% upsideOpen
2026-04-13Mizuho Securities$8107.8% upsideOpen
2026-04-08Truist Financial$655.8% upsideOpen
2025-11-24Truist Financial$9133.8% upsideOpen
2025-09-02H.C. Wainwright$11185.7% upsideOpen
2025-08-26RBC CapitalDouglas Miehm$8107.8% upsideOpen
2025-08-25H.C. Wainwright$9133.8% upsideOpen
2024-08-28OppenheimerSteven Lichtman$12211.7% upsideOpen
2023-10-10WedbushAndreas Argyrides$10159.7% upsideOpen

Mannkind (MNKD) FAQ

Mannkind (MNKD) currently reports a target price of $10. Use the charts on this page to explore Mannkind's target price history and peer comparisons.

Analysts' average 12-month price target for Mannkind is $10, about 170.9% upside from the current share price of $3.85. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $10, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mannkind, and consider following MNKD for alerts when major investors trade the stock.

Mannkind is classified in the Healthcare sector. On target price, it currently shows $10. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MNKD with unrelated industries.